Cellular-based therapy for osteonecrosis.

[1]  Ken Kumagai,et al.  Cellular strategies for enhancement of fracture repair. , 2008, The Journal of bone and joint surgery. American volume.

[2]  L. Bonewald,et al.  Osteocyte messages from a bony tomb. , 2007, Cell metabolism.

[3]  Chao Wan,et al.  The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. , 2007, The Journal of clinical investigation.

[4]  S. Khosla,et al.  Remodeling and Vascular Spaces in Bone , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  E Jones,et al.  Growing bone and cartilage. The role of mesenchymal stem cells. , 2006, The Journal of bone and joint surgery. British volume.

[6]  F Beaujean,et al.  Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. , 2005, The Journal of bone and joint surgery. American volume.

[7]  P. Hernigou,et al.  The use of percutaneous autologous bone marrow transplantation in nonunion and avascular necrosis of bone. , 2005, The Journal of bone and joint surgery. British volume.

[8]  M. Urist,et al.  Treatment of Osteonecrosis of the Femoral Head with Core Decompression and Human Bone Morphogenetic Protein , 2004, Clinical orthopaedics and related research.

[9]  S. Tian,et al.  Direct chemotactic action of angiopoietin-1 on mesenchymal cells in the presence of VEGF. , 2004, Microvascular research.

[10]  S. Dimmeler,et al.  Endothelial Progenitor Cells: Characterization and Role in Vascular Biology , 2004, Circulation research.

[11]  Cao Yang,et al.  Basic fibroblast growth factor gene transfection to enhance the repair of avascular necrosis of the femoral head. , 2004, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.

[12]  Celso Matos,et al.  Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study. , 2004, The Journal of bone and joint surgery. American volume.

[13]  R. Weinstein,et al.  Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. , 2004, Endocrinology.

[14]  M. Burnett,et al.  Marrow-Derived Stromal Cells Express Genes Encoding a Broad Spectrum of Arteriogenic Cytokines and Promote In Vitro and In Vivo Arteriogenesis Through Paracrine Mechanisms , 2004, Circulation research.

[15]  W. Schaper,et al.  Bone marrow-Derived Cells Do Not Incorporate Into the Adult Growing Vasculature , 2004, Circulation research.

[16]  R. Midura,et al.  Practical Modeling Concepts for Connective Tissue Stem Cell and Progenitor Compartment Kinetics , 2003, Journal of biomedicine & biotechnology.

[17]  J. Vermeesch,et al.  Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane , 2003, The Journal of cell biology.

[18]  Christie M. Orschell,et al.  Peripheral Blood “Endothelial Progenitor Cells” Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth Factors , 2003, Circulation.

[19]  M. Hinsenkamp,et al.  Abnormalities in the replicative capacity of osteoblastic cells in the proximal femur of patients with osteonecrosis of the femoral head. , 2003, The Journal of rheumatology.

[20]  Hung-Fat Tse,et al.  Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation , 2003, The Lancet.

[21]  Bernd Westphal,et al.  Autologous bone-marrow stem-cell transplantation for myocardial regeneration , 2003, The Lancet.

[22]  P. Hernigou,et al.  Treatment of Osteonecrosis With Autologous Bone Marrow Grafting , 2002, Clinical orthopaedics and related research.

[23]  Paul Emery,et al.  Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. , 2002, Arthritis and rheumatism.

[24]  P. Wernet,et al.  Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans , 2002, Circulation.

[25]  L. Muul,et al.  Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[26]  P. Saftig,et al.  The Bone Lining Cell: Its Role in Cleaning Howship's Lacunae and Initiating Bone Formation , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  Flemming Melsen,et al.  Cancellous Bone Remodeling Occurs in Specialized Compartments Lined by Cells Expressing Osteoblastic Markers , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  H. Blau,et al.  The Evolving Concept of a Stem Cell Entity or Function? , 2001, Cell.

[29]  Ashok K. Goel,et al.  Role of percutaneous bone marrow grafting in delayed unions, non-unions and poor regenerates. , 2001, Indian journal of medical sciences.

[30]  C. Glueck,et al.  Hypofibrinolysis, Thrombophilia, Osteonecrosis , 2001, Clinical orthopaedics and related research.

[31]  I. Black,et al.  Adult rat and human bone marrow stromal stem cells differentiate into neurons. , 2001, Blood cells, molecules & diseases.

[32]  David M. Bodine,et al.  Bone marrow cells regenerate infarcted myocardium , 2001, Nature.

[33]  P. Revell,et al.  The extent of osteocyte death in the proximal femur of patients with osteonecrosis of the femoral head. , 2001, The Journal of bone and joint surgery. British volume.

[34]  S. Homma,et al.  Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function , 2001, Nature Medicine.

[35]  R. Weinstein,et al.  Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. , 2000, The Journal of clinical endocrinology and metabolism.

[36]  A. Parfitt.  The mechanism of coupling: a role for the vasculature. , 2000, Bone.

[37]  J M Slack,et al.  Stem cells in epithelial tissues. , 2000, Science.

[38]  Eric E. Johnson,et al.  Human Bone Morphogenetic Protein Allografting for Reconstruction of Femoral Nonunion , 2000, Clinical orthopaedics and related research.

[39]  I. Weissman,et al.  Stem Cells Units of Development, Units of Regeneration, and Units in Evolution , 2000, Cell.

[40]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[41]  Darwin J. Prockop,et al.  Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta , 1999, Nature Medicine.

[42]  P. Hernigou,et al.  Decrease in the mesenchymal stem-cell pool in the proximal femur in corticosteroid-induced osteonecrosis. , 1999, The Journal of bone and joint surgery. British volume.

[43]  J. Isner,et al.  Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb. , 1998, Circulation.

[44]  J. Poser,et al.  Potential Role of Fibroblast Growth Factor in Enhancement of Fracture Healing , 1998, Clinical orthopaedics and related research.

[45]  M. Bostrom,et al.  Transforming growth factor beta in fracture repair. , 1998, Clinical orthopaedics and related research.

[46]  S. Rafii,et al.  Evidence for circulating bone marrow-derived endothelial cells. , 1998, Blood.

[47]  A. Parfitt,et al.  Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. , 1998, The Journal of clinical investigation.

[48]  V. Goldberg,et al.  The Effect of Implants Loaded with Autologous Mesenchymal Stem Cells on the Healing of Canine Segmental Bone Defects* , 1998, The Journal of bone and joint surgery. American volume.

[49]  C. Boehm,et al.  Aspiration to Obtain Osteoblast Progenitor Cells from Human Bone Marrow: The Influence of Aspiration Volume* , 1997, The Journal of bone and joint surgery. American volume.

[50]  P. Reinert,et al.  Bone-marrow transplantation in sickle-cell disease. Effect on osteonecrosis: a case report with a four-year follow-up. , 1997, The Journal of bone and joint surgery. American volume.

[51]  P. Hernigou,et al.  Abnormalities in the Bone Marrow of the Iliac Crest in Patients Who Have Osteonecrosis Secondary to Corticosteroid Therapy or Alcohol Abuse* , 1997, The Journal of bone and joint surgery. American volume.

[52]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[53]  J. Zerwekh,et al.  Porous ceramics as bone graft substitutes in long bone defects: A biomechanical, histological, and radiographic analysis , 1996, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[54]  J O Hollinger,et al.  Role of bone substitutes. , 1996, Clinical orthopaedics and related research.

[55]  J. Connolly,et al.  Injectable bone marrow preparations to stimulate osteogenic repair. , 1995, Clinical orthopaedics and related research.

[56]  S. Cook,et al.  Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. , 1994, Clinical orthopaedics and related research.

[57]  E. Wang,et al.  Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. , 1993, Clinical orthopaedics and related research.

[58]  A. Parfitt,et al.  Relationship between bone formation rate and osteoblast surface on different subdivisions of the endosteal envelope in aging & osteoporosis. , 1992, Bone.

[59]  J F Connolly,et al.  Autologous marrow injection as a substitute for operative grafting of tibial nonunions. , 1991, Clinical orthopaedics and related research.

[60]  M. Chapman,et al.  Autogeneic bone marrow and porous biphasic calcium phosphate ceramic for segmental bone defects in the canine ulna. , 1991, Clinical orthopaedics and related research.

[61]  J. Healey,et al.  Percutaneous bone marrow grafting of delayed union and nonunion in cancer patients. , 1990, Clinical orthopaedics and related research.

[62]  J. Connolly,et al.  Development of an osteogenic bone-marrow preparation. , 1989, The Journal of bone and joint surgery. American volume.

[63]  P. Simkin,et al.  Hypothesis: retrograde embolization of marrow fat may cause osteonecrosis. , 1987, The Journal of rheumatology.

[64]  Jones Jp.  Fat embolism and osteonecrosis. , 1985 .

[65]  Gj Wang,et al.  Fat-cell changes as a mechanism of avascular necrosis of the femoral head in cortisone-treated rabbits. , 1977, The Journal of bone and joint surgery. American volume.

[66]  J. Chalmers,et al.  The management of fresh ruptures of the tendo achillis. , 1970, The Journal of bone and joint surgery. American volume.

[67]  Ashok K. Goel,et al.  Percutaneous bone marrow grafting for the treatment of tibial non-union. , 2005, Injury.

[68]  J. Pasteels,et al.  Medullary impairment at early stage of non-traumatic osteonecrosis of the femoral head , 2004, Rheumatology International.

[69]  J. Callaghan,et al.  Osteonecrosis of the hip: management in the 21st century. , 2003, Instructional course lectures.

[70]  W. Hozack,et al.  A simple, high-yield method for obtaining multipotential mesenchymal progenitor cells from trabecular bone , 2003, Molecular biotechnology.

[71]  T. Allen,et al.  Pericyte differentiation. , 1995, Clinical orthopaedics and related research.

[72]  F. Bernaudin,et al.  [Course of bone tissue after bone marrow allograft in adolescents with sickle cell disease]. , 1994, Revue de chirurgie orthopedique et reparatrice de l'appareil moteur.

[73]  D. Fisher.  The role of fat embolism in the etiology of corticosteroid-induced avascular necrosis: clinical and experimental results. , 1978, Clinical orthopaedics and related research.